An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for authority to control.

SB 326 updates Pennsylvania's Controlled Substance Act to automatically align the state's scheduling of substances with federal changes. It requires the state health secretary to add federally controlled substances to Pennsylvania's schedule within 30 days of federal action, unless objections are filed within that period. If objections are raised, the secretary must hold a hearing and issue a final order before scheduling takes effect. This affects the Pennsylvania Department of Health and regulated entities like pharmacies, healthcare providers, and businesses handling controlled substances.